Skip to main content
Erschienen in: Current Allergy and Asthma Reports 12/2020

09.11.2020 | COVID-19 | Rhinosinusitis (J Mullol, Section Editor) Zur Zeit gratis

Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)

verfasst von: Irma Yolanda Castillo-López, Luis Humberto Govea-Camacho, Iván Alejandro Rodríguez-Torres, Denisse Alejandra Recio-Macías, Isam Alobid, Joaquim Mullol

Erschienen in: Current Allergy and Asthma Reports | Ausgabe 12/2020

Einloggen, um Zugang zu erhalten

Abstract

Purpose of Review

To study the prevalence of olfactory loss and its associated factors in a Mexican population a cross-sectional analytical study based on a population interviewed about health, epidemiologic aspects, and sense of smell (tested with four scents: rose, banana, perfume, and gas) was conducted to evaluate olfactory detection, memory, and identification. Levels of sense of smell perception were determined when the participants detected, recognized, or identified all (normosmia), 1–3 (hyposmia), or none (anosmia) of the odorants. Associated factors of olfactory dysfunction were identified by multivariate analysis (odds ratio, 95%CI).

Recent Findings

Olfactory dysfunction is a prevalent disorder affecting up to 20% of the general population. In addition to viral infection, including COVID-19, a number of other causes and factors may also be involved.

Summary

1,956 surveys were conducted and 1,921 were analyzed. Most of the participants (62.1%) were women. The general prevalence of olfactory dysfunction, regarding detection, was 7.2% (7.1% hyposmia, 0.1% anosmia). Age-related olfactory deterioration was observed in both sexes from the 5th decade of life (OR 2.74, p = 0.0050). Women showed better olfactory identification (OR 0.73, p = 0.0010). Obesity (OR 1.97, p = 0.0070), low educational level, bad/very bad self-perceived olfactory function (OR 2.74, p = 0.0050), olfactory loss for less than one week (OR 1.35, p = 0.0030), exposure to toxics/irritants (OR 1.31, p = 0.0030), active smoking (OR 1.58, p < 0.0010), and type 2 diabetes mellitus (OR 2.68, 95%CI 1.74–4.10, p < 0.0001) were identified as factors associated with olfactory dysfunction. These results in a Mexican population suggest better olfactory identification (verbalization) in females. Age was a determining factor in the olfactory deterioration process and obesity and diabetes mellitus were also associated with olfactory disorders. Finally, these findings reinforce the differential diagnosis with other potential causes of sense of smell loss, during the COVID-19 outbreak.
Literatur
1.
Zurück zum Zitat •• Mullol J, Alobid I, Mariño-Sánchez F, Izquierdo-Dominguez A, et al. The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep. 2020;20(10):61. https://doi.org/10.1007/s11882-020-00961-1 On March 2020, scientific societies from many countries reported sudden and severe olfactory loss commonly as an isolated symptom in COVID-19, with a wide variation on the incidence reported. •• Mullol J, Alobid I, Mariño-Sánchez F, Izquierdo-Dominguez A, et al. The loss of smell and taste in the COVID-19 outbreak: a tale of many countries. Curr Allergy Asthma Rep. 2020;20(10):61. https://​doi.​org/​10.​1007/​s11882-020-00961-1 On March 2020, scientific societies from many countries reported sudden and severe olfactory loss commonly as an isolated symptom in COVID-19, with a wide variation on the incidence reported.
3.
Zurück zum Zitat Heidari F, Karim E, Firouzifar M, Khamushian P, et al. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020;58(3):302–3.PubMed Heidari F, Karim E, Firouzifar M, Khamushian P, et al. Anosmia as a prominent symptom of COVID-19 infection. Rhinology. 2020;58(3):302–3.PubMed
5.
Zurück zum Zitat • Ekström I, Sjölund S, Nordin S, et al. Smell loss predicts mortality risk regardless of dementia conversion. J Am Geriatr Soc. 2017;65(6):1238–43 This study showed that mortality can be predicted from a subjective olfactory impairment, with participants with impairment being 30% more likely to die.PubMed • Ekström I, Sjölund S, Nordin S, et al. Smell loss predicts mortality risk regardless of dementia conversion. J Am Geriatr Soc. 2017;65(6):1238–43 This study showed that mortality can be predicted from a subjective olfactory impairment, with participants with impairment being 30% more likely to die.PubMed
6.
Zurück zum Zitat Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Masurkar A, et al. Olfactory identification deficits and increased mortality in the community. Ann Neurol. 2015;78(3):401–11.PubMedPubMedCentral Devanand DP, Lee S, Manly J, Andrews H, Schupf N, Masurkar A, et al. Olfactory identification deficits and increased mortality in the community. Ann Neurol. 2015;78(3):401–11.PubMedPubMedCentral
7.
8.
Zurück zum Zitat Obando A, Alobid I, Gastón F, Berenguer J, Marin C, Mullol J. Should postviral anosmia be further investigated? Allergy Eur J Allergy Clin Immunol. 2009;64(10):1556–7. Obando A, Alobid I, Gastón F, Berenguer J, Marin C, Mullol J. Should postviral anosmia be further investigated? Allergy Eur J Allergy Clin Immunol. 2009;64(10):1556–7.
9.
Zurück zum Zitat Jaume F, Quintó L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018;8(1):e018788.PubMedPubMedCentral Jaume F, Quintó L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018;8(1):e018788.PubMedPubMedCentral
10.
Zurück zum Zitat Marin C, Laxe S, Langdon C, Berenguer J, Lehrer E, Mariño-Sánchez F, et al. Olfactory function in an excitotoxic model for secondary neuronal degeneration: role of dopaminergic interneurons. Neuroscience. 2017;364:28–44.PubMed Marin C, Laxe S, Langdon C, Berenguer J, Lehrer E, Mariño-Sánchez F, et al. Olfactory function in an excitotoxic model for secondary neuronal degeneration: role of dopaminergic interneurons. Neuroscience. 2017;364:28–44.PubMed
11.
Zurück zum Zitat Kern RC, Quinn B, Rosseau G, Farbman AI. Post-traumatic olfactory dysfunction. Laryngoscope. 2000;110(12):2106–9.PubMed Kern RC, Quinn B, Rosseau G, Farbman AI. Post-traumatic olfactory dysfunction. Laryngoscope. 2000;110(12):2106–9.PubMed
12.
Zurück zum Zitat Langdon C, Lehrer E, Berenguer J, Laxe S, Alobid I, Quintó L, et al. Olfactory training in post-traumatic smell impairment: mild improvement in threshold performances: results from a randomized controlled trial. J Neurotrauma. 2018;35(22):2641–52.PubMed Langdon C, Lehrer E, Berenguer J, Laxe S, Alobid I, Quintó L, et al. Olfactory training in post-traumatic smell impairment: mild improvement in threshold performances: results from a randomized controlled trial. J Neurotrauma. 2018;35(22):2641–52.PubMed
13.
Zurück zum Zitat Doty RL, Deems D, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38(8):1237–44.PubMed Doty RL, Deems D, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology. 1988;38(8):1237–44.PubMed
14.
Zurück zum Zitat Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Hardy J, et al. PREDICT-PD: identifying risk of Parkinson’s disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry. 2014;85(1):31–7.PubMed Noyce AJ, Bestwick JP, Silveira-Moriyama L, Hawkes CH, Knowles CH, Hardy J, et al. PREDICT-PD: identifying risk of Parkinson’s disease in the community: methods and baseline results. J Neurol Neurosurg Psychiatry. 2014;85(1):31–7.PubMed
15.
Zurück zum Zitat Marin C, Vilas D, Langdon C, Alobid I, López-Chacón M, Haehner A, et al. Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep. 2018;18(8):42.PubMed Marin C, Vilas D, Langdon C, Alobid I, López-Chacón M, Haehner A, et al. Olfactory dysfunction in neurodegenerative diseases. Curr Allergy Asthma Rep. 2018;18(8):42.PubMed
16.
Zurück zum Zitat Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope. 2001;111(1):9–14.PubMed Seiden AM, Duncan HJ. The diagnosis of a conductive olfactory loss. Laryngoscope. 2001;111(1):9–14.PubMed
17.
Zurück zum Zitat Guilemany JM, Mariño-Sánchez FS, Angrill J, Alobid I, Centellas S, Pujols L, et al. The importance of smell in patients with bronchiectasis. Respir Med. 2011;105(1):44–9.PubMed Guilemany JM, Mariño-Sánchez FS, Angrill J, Alobid I, Centellas S, Pujols L, et al. The importance of smell in patients with bronchiectasis. Respir Med. 2011;105(1):44–9.PubMed
18.
Zurück zum Zitat Guilemany JM, Angrill J, Alobid I, Centellas S, Prades E, Roca J, et al. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient’s quality of life. Allergy Eur J Allergy Clin Immunol. 2009;64(10):1524–9. Guilemany JM, Angrill J, Alobid I, Centellas S, Prades E, Roca J, et al. United airways: the impact of chronic rhinosinusitis and nasal polyps in bronchiectasic patient’s quality of life. Allergy Eur J Allergy Clin Immunol. 2009;64(10):1524–9.
19.
Zurück zum Zitat Alobid I, Benítez P, Cardelús S, de Borja Callejas F, Lehrer-Coriat E, Pujols L, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124(1):50–6.PubMed Alobid I, Benítez P, Cardelús S, de Borja Callejas F, Lehrer-Coriat E, Pujols L, et al. Oral plus nasal corticosteroids improve smell, nasal congestion, and inflammation in sino-nasal polyposis. Laryngoscope. 2014;124(1):50–6.PubMed
20.
Zurück zum Zitat Guilemany JM, García-Piñero A, Alobid I, Cardelús S, Centellas S, Bartra J, et al. Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope. 2009;119(2):233–8.PubMed Guilemany JM, García-Piñero A, Alobid I, Cardelús S, Centellas S, Bartra J, et al. Persistent allergic rhinitis has a moderate impact on the sense of smell, depending on both nasal congestion and inflammation. Laryngoscope. 2009;119(2):233–8.PubMed
21.
Zurück zum Zitat Langdon C, Guilemany JM, Valls M, Alobid I, Bartra J, Dávila I, et al. Allergic rhinitis causes loss of smell in children: the OLFAPEDRIAL study. Pediatr Allergy Immunol. 2016;27(8):867–70.PubMed Langdon C, Guilemany JM, Valls M, Alobid I, Bartra J, Dávila I, et al. Allergic rhinitis causes loss of smell in children: the OLFAPEDRIAL study. Pediatr Allergy Immunol. 2016;27(8):867–70.PubMed
22.
Zurück zum Zitat Mariño-Sanchez F, Valls-Mateus M, Haag O, Alobid I, Bousquet J, Mullol J. Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2018;6(5):1752–5.PubMed Mariño-Sanchez F, Valls-Mateus M, Haag O, Alobid I, Bousquet J, Mullol J. Smell loss is associated with severe and uncontrolled disease in children and adolescents with persistent allergic rhinitis. J Allergy Clin Immunol Pract. 2018;6(5):1752–5.PubMed
23.
Zurück zum Zitat Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114(10):1764–9.PubMed Landis BN, Konnerth CG, Hummel T. A study on the frequency of olfactory dysfunction. Laryngoscope. 2004;114(10):1764–9.PubMed
24.
Zurück zum Zitat Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288(18):2307–12.PubMed Murphy C, Schubert CR, Cruickshanks KJ, Klein BE, Klein R, Nondahl DM. Prevalence of olfactory impairment in older adults. JAMA. 2002;288(18):2307–12.PubMed
25.
Zurück zum Zitat Wysocki CJ, Gilbert AN. National Geographic Smell Survey: effects of age are Heterogenous. Ann N Y Acad Sci. 1989;561(1):12–28.PubMed Wysocki CJ, Gilbert AN. National Geographic Smell Survey: effects of age are Heterogenous. Ann N Y Acad Sci. 1989;561(1):12–28.PubMed
26.
Zurück zum Zitat Lin S-H, Chu S-T, Yuan B-C, Shu CH. Survey of the frequency of olfactory dysfunction in Taiwan. J Chin Med Assoc. 2009;72(2):68–71.PubMed Lin S-H, Chu S-T, Yuan B-C, Shu CH. Survey of the frequency of olfactory dysfunction in Taiwan. J Chin Med Assoc. 2009;72(2):68–71.PubMed
27.
Zurück zum Zitat Brämerson A, Johansson L, Ek L, et al. Prevalence of olfactory dysfunction: the skövde population-based study. Laryngoscope. 2004;114(4):733–7.PubMed Brämerson A, Johansson L, Ek L, et al. Prevalence of olfactory dysfunction: the skövde population-based study. Laryngoscope. 2004;114(4):733–7.PubMed
28.
Zurück zum Zitat •• Liu G, Zong G, Doty RL, et al. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: A cross-sectional study. BMJ Open. 2016;6(11):8–11 The study demonstrated associations of age, gender, ethnicity, educational attainment, family income, alcohol consumption, and history of asthma, cancer or cardiovascular disease with chemosensory disorders on a nationwide scale. •• Liu G, Zong G, Doty RL, et al. Prevalence and risk factors of taste and smell impairment in a nationwide representative sample of the US population: A cross-sectional study. BMJ Open. 2016;6(11):8–11 The study demonstrated associations of age, gender, ethnicity, educational attainment, family income, alcohol consumption, and history of asthma, cancer or cardiovascular disease with chemosensory disorders on a nationwide scale.
29.
Zurück zum Zitat Mullol J, Alobid I, Mariño-Sánchez F, Quintó L, de Haro J, Bernal-Sprekelsen M, et al. Furthering the understanding of olfaction, the prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open. 2012;2(6):e001256.PubMedPubMedCentral Mullol J, Alobid I, Mariño-Sánchez F, Quintó L, de Haro J, Bernal-Sprekelsen M, et al. Furthering the understanding of olfaction, the prevalence of loss of smell and risk factors: a population-based survey (OLFACAT study). BMJ Open. 2012;2(6):e001256.PubMedPubMedCentral
30.
Zurück zum Zitat WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (‎1993 : Geneva, Switzerland)‎ & World Health Organization. Physical status : the use of and interpretation of anthropometry, report of a WHO expert committee. World Health Organization; 1995. https://apps.who.int/iris/handle/10665/37003. WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (‎1993 : Geneva, Switzerland)‎ & World Health Organization. Physical status : the use of and interpretation of anthropometry, report of a WHO expert committee. World Health Organization; 1995. https://​apps.​who.​int/​iris/​handle/​10665/​37003.
31.
Zurück zum Zitat Partida Bush, Virgilio. Proyecciones de la población de México, de las entidades federativas, de los municipios y de las localidades 2005-2050, Documento metodológico, Consejo Nacional de Población, México. 2008. Partida Bush, Virgilio. Proyecciones de la población de México, de las entidades federativas, de los municipios y de las localidades 2005-2050, Documento metodológico, Consejo Nacional de Población, México. 2008.
32.
Zurück zum Zitat Larsson M, Finkel D, Pedersen NL. Odor identification: influences of age, gender, cognition, and personality. J Gerontol Ser B Psychol Sci Soc Sci. 2000;55(5):P304–10. Larsson M, Finkel D, Pedersen NL. Odor identification: influences of age, gender, cognition, and personality. J Gerontol Ser B Psychol Sci Soc Sci. 2000;55(5):P304–10.
33.
Zurück zum Zitat Hummel T, Whitcroft K, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology. 2017;54(Suppl 26):1–30.PubMed Hummel T, Whitcroft K, Andrews P, et al. Position paper on olfactory dysfunction. Rhinology. 2017;54(Suppl 26):1–30.PubMed
34.
Zurück zum Zitat Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. The rate of age-related olfactory decline among the general population of older U.S. adults. J Gerontol A Biol Sci Med Sci. 2015;70(11):1435–41.PubMedPubMedCentral Pinto JM, Wroblewski KE, Kern DW, Schumm LP, McClintock MK. The rate of age-related olfactory decline among the general population of older U.S. adults. J Gerontol A Biol Sci Med Sci. 2015;70(11):1435–41.PubMedPubMedCentral
35.
Zurück zum Zitat Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev. 2004;3(2):215–32.PubMed Kovács T. Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders. Ageing Res Rev. 2004;3(2):215–32.PubMed
37.
Zurück zum Zitat Schubert CR, Cruickshanks KJ, Fischer ME, Huang GH, Klein BEK, Klein R, et al. Olfactory impairment in an adult population: the beaver dam offspring study. Chem Senses. 2012;37(4):325–34.PubMed Schubert CR, Cruickshanks KJ, Fischer ME, Huang GH, Klein BEK, Klein R, et al. Olfactory impairment in an adult population: the beaver dam offspring study. Chem Senses. 2012;37(4):325–34.PubMed
38.
Zurück zum Zitat Vennemann MM, Hummel T, Berger K. The association between smoking and smell and taste impairment in the general population. J Neurol. 2008;255(8):1121–6. Vennemann MM, Hummel T, Berger K. The association between smoking and smell and taste impairment in the general population. J Neurol. 2008;255(8):1121–6.
39.
Zurück zum Zitat Gouveri E, Katotomichelakis M, Gouveris H, Danielides V, Maltezos E, Papanas N. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology. 2014;65(10):869–76.PubMed Gouveri E, Katotomichelakis M, Gouveris H, Danielides V, Maltezos E, Papanas N. Olfactory dysfunction in type 2 diabetes mellitus: an additional manifestation of microvascular disease? Angiology. 2014;65(10):869–76.PubMed
40.
Zurück zum Zitat Schab F. Odor memory: taking stock. Psychol Bull. 1991;109(2):242–51.PubMed Schab F. Odor memory: taking stock. Psychol Bull. 1991;109(2):242–51.PubMed
41.
Zurück zum Zitat Ochsenbein-Kölble N, von Mering R, Zimmermann R, Hummel T. Changes in olfactory function in pregnancy and postpartum. Int J Gynecol Obstet. 2007;97(1):10–4. Ochsenbein-Kölble N, von Mering R, Zimmermann R, Hummel T. Changes in olfactory function in pregnancy and postpartum. Int J Gynecol Obstet. 2007;97(1):10–4.
42.
Zurück zum Zitat Gilbert A, Wysocki C. Quantitative Assessment of Olfactory Experience during Pregnancy Reports such as the two quoted above are familiar to medical personnel caring for pregnant women. A change in odor perception during pregnancy is a seemingly frequent event. As described. Psychosom Med. 1991;53:693–700.PubMed Gilbert A, Wysocki C. Quantitative Assessment of Olfactory Experience during Pregnancy Reports such as the two quoted above are familiar to medical personnel caring for pregnant women. A change in odor perception during pregnancy is a seemingly frequent event. As described. Psychosom Med. 1991;53:693–700.PubMed
43.
Zurück zum Zitat Swallow B, Lindow S, Masson E, et al. Women with nausea and vomiting in pregnancy demonstrate worse health and are adversely affected by odours. J Obstet Gynaecol. 2005;25(6):544–9.PubMed Swallow B, Lindow S, Masson E, et al. Women with nausea and vomiting in pregnancy demonstrate worse health and are adversely affected by odours. J Obstet Gynaecol. 2005;25(6):544–9.PubMed
44.
Zurück zum Zitat Laska M, Koch B, Heid B. Failure to demonstrate systematic changes in olfactory perception in the course of pregnancy. Chem Senses. 1996;21(5):567–71.PubMed Laska M, Koch B, Heid B. Failure to demonstrate systematic changes in olfactory perception in the course of pregnancy. Chem Senses. 1996;21(5):567–71.PubMed
45.
Zurück zum Zitat Cameron E. Measures of human olfactory perception during pregnancy. Chem Senses. 2007;32(8):775–82.PubMed Cameron E. Measures of human olfactory perception during pregnancy. Chem Senses. 2007;32(8):775–82.PubMed
46.
Zurück zum Zitat Barrera-Cruz A, Rodríguez-González A, Molina-Ayala MA. The current state of obesity in Mexico. Rev Med Inst Mex Seguro Soc. 2013;51(3):292–9.PubMed Barrera-Cruz A, Rodríguez-González A, Molina-Ayala MA. The current state of obesity in Mexico. Rev Med Inst Mex Seguro Soc. 2013;51(3):292–9.PubMed
47.
Zurück zum Zitat Thiebaud N, Johnson MC, Butler JL, Bell GA, Ferguson KL, Fadool AR, et al. Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning. J Neurosci. 2014;34(20):6970–84.PubMedPubMedCentral Thiebaud N, Johnson MC, Butler JL, Bell GA, Ferguson KL, Fadool AR, et al. Hyperlipidemic diet causes loss of olfactory sensory neurons, reduces olfactory discrimination, and disrupts odor-reversal learning. J Neurosci. 2014;34(20):6970–84.PubMedPubMedCentral
48.
Zurück zum Zitat Fernández-Aranda F, Agüera Z, Fernández-García J, et al. Smell–taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions. Endocrine. 2016;51(2):256–67.PubMed Fernández-Aranda F, Agüera Z, Fernández-García J, et al. Smell–taste dysfunctions in extreme weight/eating conditions: analysis of hormonal and psychological interactions. Endocrine. 2016;51(2):256–67.PubMed
49.
Zurück zum Zitat •• Gopinath B, Russel J, Sue CM, Flood VM, Burlutsky G, Mitchell P. Olfactory impairment in older adults is associated with poorer diet quality over 5-years. Eur J Nutr. 2016;55(3):1081–7 The epidemiological data proposed to reinforces the importance of olfaction in following dietary guidelines and in the nutritional intake of older adults, particularly women.PubMed •• Gopinath B, Russel J, Sue CM, Flood VM, Burlutsky G, Mitchell P. Olfactory impairment in older adults is associated with poorer diet quality over 5-years. Eur J Nutr. 2016;55(3):1081–7 The epidemiological data proposed to reinforces the importance of olfaction in following dietary guidelines and in the nutritional intake of older adults, particularly women.PubMed
50.
Zurück zum Zitat Weinstock R, Wright H, Smith D. Olfactory dysfunction in diabetes mellitus. Physiol Behav. 1993;53(1):17–21.PubMed Weinstock R, Wright H, Smith D. Olfactory dysfunction in diabetes mellitus. Physiol Behav. 1993;53(1):17–21.PubMed
51.
Zurück zum Zitat Naka A, Riedl M, Luger A, Hummel T, Mueller CA. Clinical significance of smell and taste disorders in patients with diabetes mellitus. Eur Arch Otorhinolaryngol. 2010;267:547–50.PubMed Naka A, Riedl M, Luger A, Hummel T, Mueller CA. Clinical significance of smell and taste disorders in patients with diabetes mellitus. Eur Arch Otorhinolaryngol. 2010;267:547–50.PubMed
52.
Zurück zum Zitat Gascón C, Santaolalla F, Martínez A, Sánchez del Rey A. Usefulness of the BAST-24 smell and taste test in the study of diabetic patients: a new approach to the determination of renal function. Acta Otolaryngol. 2013;133(4):400–4.PubMed Gascón C, Santaolalla F, Martínez A, Sánchez del Rey A. Usefulness of the BAST-24 smell and taste test in the study of diabetic patients: a new approach to the determination of renal function. Acta Otolaryngol. 2013;133(4):400–4.PubMed
53.
Zurück zum Zitat Finkel D, Pedersen N, Larsson M. Olfactory functioning and cognitive abilities: a twin study. J Gerontol B Psychol Sci Soc Sci. 2001;56(4):P226–33.PubMed Finkel D, Pedersen N, Larsson M. Olfactory functioning and cognitive abilities: a twin study. J Gerontol B Psychol Sci Soc Sci. 2001;56(4):P226–33.PubMed
54.
Zurück zum Zitat Upadhyay U, Holbrook E. Olfactory loss as a result of toxic exposure. Otolaryngol Clin N Am. 2004;37(6):1185–207. Upadhyay U, Holbrook E. Olfactory loss as a result of toxic exposure. Otolaryngol Clin N Am. 2004;37(6):1185–207.
55.
Zurück zum Zitat Deems D, Doty R, Settle G, et al. Smell and taste disorders, a study of 750 patients from the University-of-Pennsylvania smell and taste center. Arch Otolaryngol Neck Surg. 1991;117(5):519–28. Deems D, Doty R, Settle G, et al. Smell and taste disorders, a study of 750 patients from the University-of-Pennsylvania smell and taste center. Arch Otolaryngol Neck Surg. 1991;117(5):519–28.
56.
Zurück zum Zitat Wilson R, Arnold S, Schneider J, et al. Olfactory impairment in presymptomatic Alzheimer’s disease. Ann N Y Acad Sci. 2009;1170:730–5.PubMedPubMedCentral Wilson R, Arnold S, Schneider J, et al. Olfactory impairment in presymptomatic Alzheimer’s disease. Ann N Y Acad Sci. 2009;1170:730–5.PubMedPubMedCentral
57.
Zurück zum Zitat Berendse H, Booij J, Francot C. B et al. subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol. 2001;50(1):34–41.PubMed Berendse H, Booij J, Francot C. B et al. subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol. 2001;50(1):34–41.PubMed
58.
Zurück zum Zitat Vilas D, Tolosa E, Quintana M, Pont-Sunyer C, Santos M, Casellas A, et al. Olfaction in LRRK2 linked Parkinson’s disease: is it different from idiopathic Parkinson’s disease? J Parkinsons Dis. 2020;10(3):951–8.PubMed Vilas D, Tolosa E, Quintana M, Pont-Sunyer C, Santos M, Casellas A, et al. Olfaction in LRRK2 linked Parkinson’s disease: is it different from idiopathic Parkinson’s disease? J Parkinsons Dis. 2020;10(3):951–8.PubMed
59.
Zurück zum Zitat Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, et al. Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter-deficit prodromal cohort. JAMA Neurol. 2017;74(8):933–40.PubMedPubMedCentral Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, et al. Conversion to Parkinson disease in the PARS hyposmic and dopamine transporter-deficit prodromal cohort. JAMA Neurol. 2017;74(8):933–40.PubMedPubMedCentral
60.
Zurück zum Zitat Wrobel B, Leopold D. Clinical assessment of patients with smell and taste disorders. Otolaryngol Clin N Am. 2004;37:1127–42. Wrobel B, Leopold D. Clinical assessment of patients with smell and taste disorders. Otolaryngol Clin N Am. 2004;37:1127–42.
61.
Zurück zum Zitat de Kruijk J, Leffers P, Menheere P, et al. Olfactory function after mild traumatic brain injury. Brain Inj. 2003;17:73–8.PubMed de Kruijk J, Leffers P, Menheere P, et al. Olfactory function after mild traumatic brain injury. Brain Inj. 2003;17:73–8.PubMed
63.
Zurück zum Zitat Hernández-Ávila M, Gutiérrez J, Reynoso-Noverón D. Diabetes mellitus in Mexico. Status of the epidemic. Salud Publica Méx. 2013;55(Suppl 2):S129–36.PubMed Hernández-Ávila M, Gutiérrez J, Reynoso-Noverón D. Diabetes mellitus in Mexico. Status of the epidemic. Salud Publica Méx. 2013;55(Suppl 2):S129–36.PubMed
Metadaten
Titel
Olfactory Dysfunction in a Mexican Population Outside of COVID-19 Pandemic: Prevalence and Associated Factors (the OLFAMEX Study)
verfasst von
Irma Yolanda Castillo-López
Luis Humberto Govea-Camacho
Iván Alejandro Rodríguez-Torres
Denisse Alejandra Recio-Macías
Isam Alobid
Joaquim Mullol
Publikationsdatum
09.11.2020
Verlag
Springer US
Schlagwort
COVID-19
Erschienen in
Current Allergy and Asthma Reports / Ausgabe 12/2020
Print ISSN: 1529-7322
Elektronische ISSN: 1534-6315
DOI
https://doi.org/10.1007/s11882-020-00975-9

Weitere Artikel der Ausgabe 12/2020

Current Allergy and Asthma Reports 12/2020 Zur Ausgabe

Allergies and the Environment (T Moran, Section Editor)

The Role of Environmental Exposures in Atopic Dermatitis

Immunotherapy and Immunomodulators ( B Vickery, Section Editor)

Oral Immunotherapy for Food Allergy—a US Regulatory Perspective

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Nur selten Nachblutungen nach Abszesstonsillektomie

03.05.2024 Tonsillektomie Nachrichten

In einer Metaanalyse von 18 Studien war die Rate von Nachblutungen nach einer Abszesstonsillektomie mit weniger als 7% recht niedrig. Nur rund 2% der Behandelten mussten nachoperiert werden. Die Therapie scheint damit recht sicher zu sein.

Rezidivierender Peritonsillarabszess nach Oralsex

02.05.2024 Peritonsillarabszess Kasuistik

Die erotischen Dimensionen von Peritonsillarabszessen scheinen eng begrenzt zu sein. Das heißt aber nicht, solche Abszesse und Erotik hätten nichts miteinander gemein, wie ein Fallbericht verdeutlicht.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.